Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.34 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | LTA4H | P09960 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 2/20 | 0.32 |
| ▸ | NOS2 | P35228 | 2/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.32 |
| ▸ | GFPT1 | Q06210 | 1/20 | 0.32 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL111171 | 1.00 | KIF11 (0.43) | KIF11SMN1; SMN2ITGB1ITGA4CA1 | |
| SCHEMBL111172 | 1.00 | KIF11 (0.43) | KIF11SMN1; SMN2ITGB1ITGA4CA1 | |
| SCHEMBL12438525 | 1.00 | KIF11 (0.43) | KIF11SMN1; SMN2ITGB1ITGA4CA1 | |
| SCHEMBL12438515 | 1.00 | KIF11 (0.43) | KIF11SMN1; SMN2ITGB1ITGA4CA1 | |
| Hydrochloric Acid SCHEMBL1565157 | 0.98 | KIF11 (0.42) | KIF11SMN1; SMN2ITGB1ITGA4CA1 | |
| Hydrochloric Acid SCHEMBL2801871 | 0.98 | KIF11 (0.42) | KIF11SMN1; SMN2ITGB1ITGA4CA1 | |
| Hydrochloric Acid SCHEMBL1565156 | 0.98 | KIF11 (0.42) | KIF11SMN1; SMN2ITGB1ITGA4CA1 | |
| Hydrochloric Acid SCHEMBL29401888 | 0.98 | KIF11 (0.42) | KIF11SMN1; SMN2ITGB1ITGA4CA1 | |
| Hydrochloric Acid SCHEMBL1819809 | 0.98 | KIF11 (0.42) | KIF11SMN1; SMN2ITGB1ITGA4CA1 | |
| Water SCHEMBL28591945 | 0.98 | KIF11 (0.42) | KIF11SMN1; SMN2ITGB1ITGA4CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 777 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612518-B2 | Chemically surface modified carbon black and methods of making same | CONTINENTAL CARBON CO. (US) | 2026-04-28 | — | — | US | claimed |
| US-20260097047-A1 | Small molecule inhibitors of the ribosome biogenesis factor NVL2 | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2026-04-09 | — | — | US | claimed |
| US-20260098061-A1 | EPHA2-BINDING PENDING PEPTIDE AND COMPOSITION COMPRISING SAME | PEPTIDREAM INC (JP) | 2026-04-09 | — | — | US | claimed |
| US-20250368829-A1 | REFINED SURFACE MODIFIED CARBON BLACK AND METHODS OF MAKING SAME | CONTINENTAL CARBON CO (US) | 2025-12-04 | — | — | US | claimed |
| US-12460083-B2 | Surface modified carbon black to simultaneously improve rolling resistance, wet traction, and wear resistance | CONTINENTAL CARBON CO. (US) | 2025-11-04 | — | — | US | claimed |
| US-12391835-B2 | Refined surface modified carbon black and methods of making same | CONTINENTAL CARBON CO. (US) | 2025-08-19 | — | — | US | claimed |
| EP-4594337-A2 | RADIOPHARMACEUTICAL COMPOSITIONS TARGETING EPHRIN TYPE-A RECEPTOR 2 AND USES THEREOF | Rayzebio, Inc. (US) | 2025-08-06 | — | — | EP | claimed |
| EP-4594336-A2 | EPHA2-BINDING PENDING PEPTIDE AND COMPOSITION COMPRISING SAME | PeptiDream Inc. (JP) | 2025-08-06 | — | — | EP | claimed |
| US-20250179304-A1 | MODIFICATION OF COMMERCIAL CARBON BLACK GRADES VIA SURFACE MODIFICATION | CONTINENTAL CARBON CO. | 2025-06-05 | — | — | US | claimed |
| CN-119971823-A | Preparation process and application of serine for resisting skin aging | 广州樱特嫚生物科技有限公司 | 2025-05-13 | — | — | CN | claimed |
| US-6861401-B2 | Fabric care compositions | THE PROCTER & GAMBLE COMPANY (US) | 2005-03-01 | — | — | US | claimed |
| US-20040063599-A1 | Fabric care compositions | THE PROCTER & GAMBLE COMPANY | 2004-04-01 | — | — | US | claimed |
| US-20020137653-A1 | A bleach scavenging system comprising acyclic mercaptans, sulfides and/or disulfides and a Group IA and/or IIA metal metabisulfite, sulfite, bisulfite or thiosulfite; laundering; colorfastness; allowing polyamines to chelant heavy metals | THE PROCTER & GAMBLE COMPANY (US) | 2002-09-26 | — | — | US | claimed |
| EP-1214390-A1 | FABRIC CARE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2002-06-19 | — | — | EP | claimed |
| EP-0915123-B1 | Terminating post cure of silicone elastomers with amino acid esters | DOW CORNING (US) | 2001-05-09 | — | — | EP | claimed |
| WO-2001021746-A1 | FABRIC CARE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2001-03-29 | — | — | WO | claimed |
| US-5977280-A | Terminating post cure with amino acid esters | DOW CORNING CORPORATION (US) | 1999-11-02 | — | — | US | claimed |
| EP-0915123-A1 | Terminating post cure of silicone elastomers with amino acid esters | DOW CORNING CORPORATION (US) | 1999-05-12 | — | — | EP | claimed |
| EP-0546063-A1 | TOXIC AGENT PROTECTIVE COMPOUNDS, COMPOSITIONS AND USES | The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and (GB) | 1993-06-16 | — | — | EP | claimed |
| WO-1992004024-A2 | TOXIC AGENT PROTECTIVE COMPOUNDS, COMPOSITIONS AND METHOD | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND (GB) | 1992-03-19 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260098061-A1 | EPHA2-BINDING PENDING PEPTIDE AND COMPOSITION COMPRISING SAME | EPHA2, EPHA1, EPHB1 | KIF11 1115/4885SMN1; SMN2 2512/4885ITGB1 2790/4885 |
| US-20260097047-A1 | Small molecule inhibitors of the ribosome biogenesis factor NVL2 | NOC2L, RPS6, RPS3A | KIF11 2933/4885SMN1; SMN2 2686/4885ITGB1 4739/4885 |
| US-12612518-B2 | Chemically surface modified carbon black and methods of making same | BHMT2, CTH, BHMT | KIF11 1700/4885SMN1; SMN2 1119/4885ITGB1 231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.